WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'9501 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 18'9751 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 74'933  73'997  73'059  72'138  71'241  63'174  53'995  43'906 
Births 1'261  1'268  1'275  1'282  1'288  1'356  1'407  1'551 
Surviving infants 1'246  1'253  1'259  1'264  1'269  1'315  1'316  1'385 
Pop. less than 5 years 6'355  6'362  6'363  6'359  6'366  6'571  6'648  6'641 
Pop. less than 15 years 19'224  19'249  19'261  19'262  19'278  19'364  19'575  17'588 
Female 15-49 years 20'288  20'075  19'859  19'647  19'442  17'275  13'675  10'403 

Number of reported case

(Click for retrospective incidence data for Turkey)
Diphtheria 20  86 
Japanese encephalitis
Measles 7'405  349  111  16'244  11'372  8'618 
Mumps 597  834  1'609  1'525  2'180 
Pertussis 33  18  242  48  11  510  454  1'520 
Polio* 24  182 
Rubella 81  43  1'734  64  97 
Rubella (CRS)
Tetanus (neonatal) 26  67 
Tetanus (total) 15  11  24  25  12  38  123  48 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Turkey)
Vaccine year result method % card seen                                                
BCG 2007  96  DHS   73  96  96  96  97  96  82  16  74 
DTP1 2007  97  DHS   73  97  97  98  98  97  92 
DTP3 2007  89  DHS   73  98  97  97  97  96  85  74  42 
HepB_BD          99  97  97 
HepB3 2007  86  DHS   73  97  97  96  96  94  71 
Hib3          98  97  97  97  96 
JapEnc         
MCV 2007  89  DHS   73  98  96  98  97  97  86  67  27 
MCV2          98  85  86  91  88 
PCV1          97  97  98 
PCV3          97  97  96  93 
Pol3 2007  89  DHS   73  98  97  97  97  96  85  74  63 
Rota1         
Rota_last         
Rubella1          98  96  98  97  97 
TT2plus 1997  29  DHS   39  61  62  57  51  57  36  18 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Turkey)
BCG 96  96  96  97  96  96  93 
DTP1 99  97  98  98  97  92  94  67 
DTP3 98  97  97  97  96  85  84  42 
HepB3 97  97  96  96  94  71 
HepB_BD 99  97  97  97  96 
Hib3 98  97  97  97  96 
MCV 98  96  98  97  97  87  78  27 
MCV2 85  85  86  91  88 
PAB 90  90  90  90  71  50  20 
PCV3 97  97  96  93 
Pol3 98  97  97  97  96  85  84  63 
Rota_last

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2 months; Yes
DTaPHibIPV 2, 4, 6, 18 months; Yes
DTaPIPV 6 years; Yes
HepA 18, 24 months; Yes
HepB birth; 1, 6 months; Yes
MMR 12 months; 6 years; Yes
OPV 6, 18 months; Yes
Pneumo_conj 2, 4, 6, 12 months; Yes
Td 1st contact; +1, +6 months; +1, +1 years; Yes
Varicella 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2014-2018  2013-2017  5 years  2010-2014  2009-2013  2008-2013   
Nº of districts with microplans that include activities to raise immunization coverage number NA  81          81 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 81  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 81  81  81  81  81  81 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 75  52  73  70  65  50   
% of districts with MCV1 coverage >=95% From 0 to 100% 93  64  90  86  80  62   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.